Hedge Fund - Balyasny Asset Management
Teva Pharmaceutical Industries Ltd (TEVA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $439,782 | 0% | 28,613 | $17.86 |
| 2 | 2024 - Q4 (2024-12-31) | $18,320,508 | 0.02% | 831,239 | $18.19 |
| 3 | 2024 - Q3 (2024-09-30) | $41,229,940 | 0.06% | 2,288,010 | $17.50 |
| 4 | 2024 - Q2 (2024-06-30) | $60,823,246 | 0.1% | 3,742,969 | $15.40 |
| 5 | 2024 - Q1 (2024-03-31) | $44,051,392 | 0.07% | 3,121,998 | $12.61 |
| 6 | 2023 - Q4 (2023-12-31) | $0 | 0% | 0 | $9.34 |
| 7 | 2023 - Q3 (2023-09-30) | $5,707,084 | 0.01% | 559,518 | $9.31 |
| 8 | 2023 - Q2 (2023-06-30) | $0 | 0% | 0 | $8.11 |
| 9 | 2023 - Q1 (2023-03-31) | $16,716,792 | 0.04% | 1,888,903 | $9.89 |
| 10 | 2022 - Q4 (2022-12-31) | $16,448,285 | 0.04% | 1,803,540 | $8.73 |
| 11 | 2022 - Q3 (2022-09-30) | $0 | 0% | 0 | $8.84 |
| 12 | 2022 - Q2 (2022-06-30) | $19,849,000 | 0.06% | 2,639,446 | $8.71 |
| 13 | 2022 - Q1 (2022-03-31) | $8,484,000 | 0.02% | 903,527 | $8.35 |
| 14 | 2021 - Q4 (2021-12-31) | $158,000 | 0% | 19,744 | $9.03 |
| 15 | 2019 - Q2 (2019-06-30) | $0 | 0% | 0 | $12.06 |
| 16 | 2019 - Q1 (2019-03-31) | $25,026,000 | 0.16% | 1,596,027 | $17.63 |
| 17 | 2018 - Q4 (2018-12-31) | $12,061,000 | 0.08% | 782,165 | $20.50 |
| 18 | 2018 - Q3 (2018-09-30) | $35,038,000 | 0.15% | 1,626,628 | $23.22 |
| 19 | 2018 - Q2 (2018-06-30) | $23,248,000 | 0.1% | 955,908 | $20.39 |
| 20 | 2018 - Q1 (2018-03-31) | $27,010,000 | 0.11% | 1,580,456 | $19.52 |
| 21 | 2017 - Q4 (2017-12-31) | $10,542,000 | 0.03% | 556,290 | $15.04 |
| 22 | 2017 - Q3 (2017-09-30) | $28,968,000 | 0.11% | 1,645,926 | $22.50 |
| 23 | 2016 - Q4 (2016-12-31) | $0 | 0% | 0 | $39.93 |
| 24 | 2016 - Q3 (2016-09-30) | $6,202,000 | 0.03% | 134,803 | $52.17 |
| 25 | 2016 - Q2 (2016-06-30) | $0 | 0% | 0 | $53.24 |
| 26 | 2016 - Q1 (2016-03-31) | $10,474,000 | 0.06% | 195,732 | $58.67 |
| 27 | 2015 - Q4 (2015-12-31) | $222,540,000 | 1.54% | 3,390,308 | $61.80 |
| 28 | 2015 - Q3 (2015-09-30) | $72,163,000 | 0.53% | 1,278,134 | $64.84 |
| 29 | 2015 - Q2 (2015-06-30) | $79,251,000 | 0.48% | 1,340,963 | $61.69 |
| 30 | 2015 - Q1 (2015-03-31) | $3,966,000 | 0.03% | 63,662 | $58.14 |
| 31 | 2014 - Q4 (2014-12-31) | $40,110,000 | 0.36% | 697,444 | $55.71 |
| 32 | 2014 - Q3 (2014-09-30) | $9,391,000 | 0.07% | 174,723 | $52.98 |
| 33 | 2014 - Q2 (2014-06-30) | $20,507,000 | 0.23% | 391,214 | $51.11 |
| 34 | 2014 - Q1 (2014-03-31) | $15,071,000 | 0.17% | 285,211 | $46.22 |
| 35 | 2013 - Q4 (2013-12-31) | $5,627,000 | 0.07% | 140,400 | $39.38 |
| 36 | 2013 - Q3 (2013-09-30) | $23,295,000 | 0.31% | 616,602 | $39.01 |
| 37 | 2013 - Q2 (2013-06-30) | $31,478,000 | 0.52% | 803,013 | $38.94 |
| 38 | 2013 - Q1 (2013-03-31) | $15,427,000 | 0.23% | 388,793 | $38.59 |
| 39 | 2012 - Q4 (2012-12-31) | $3,873,000 | 0.1% | 103,731 | $39.91 |
| 40 | 2012 - Q3 (2012-09-30) | $22,985,000 | 0.52% | 555,050 | $40.44 |
| 41 | 2012 - Q1 (2012-03-31) | $0 | 0% | 0 | $44.59 |
| 42 | 2011 - Q4 (2011-12-31) | $2,477,000 | 0.13% | 61,370 | $33.60 |
| 43 | 2011 - Q2 (2011-06-30) | $0 | 0% | 0 | $40.62 |
| 44 | 2011 - Q1 (2011-03-31) | $7,776,000 | 0.34% | 155,000 | $42.98 |
The displayed share prices are average quarterly stock market prices.